Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Signal Genetics Cmn (SGNL)

12.30 -2.20 (-15.17%)

2/13/2017  4:00pm

Open:

N/A

Pre. Close:

14.50

High:

N/A

Low:

N/A

Volume:

0

Market Cap:

N/A

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

13.08 - 13.42

13.42 - 13.76

Low:

9.54 - 9.76

9.76 - 9.99

Close:

11.84 - 12.28

12.28 - 12.73

Technical analysis  (as of: 2017-02-24 4:37:54 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 20.72     One year: 24.20

Support:

Support1: 9.72    Support2: 4.76

Resistance:

Resistance1: 17.74    Resistance2: 20.72

Pivot:

10.81

Moving Averages:

MA(5): 13.61     MA(20): 10.50

MA(100): 7.83     MA(250): 7.86

MACD:

MACD(12,26): 1.38     Signal(12,26,9): 1.01

%K %D:

%K(14,3): 67.70     %D(3): 72.33

RSI:

RSI(14): 58.59

52-Week:

High: 17.74  Low: 0.12  Change(%): 46.4

Average Vol(K):

3-Month: 73  10-Days 67

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SGNL has closed below upper band by 32.0%. Bollinger Bands are 60.9% wider than normal. The large width of the bands suggest high volatility as compared to SGNL's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Mon, 13 Feb 2017 21:18:59 GMT
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40 ...

Sat, 25 Feb 2017 06:22:30 GMT
Insider Trading Activity Miragen Therapeutics, Inc. (NASDAQ:MGEN) – Director ...

Tue, 21 Feb 2017 14:15:00 GMT
Why miRagen Therapeutics Shares Could See 60% Upside By 2018

Tue, 01 Nov 2016 00:02:36 GMT
miRagen Therapeutics and Signal Genetics Sign Merger Agreement

Thu, 12 Nov 2015 12:00:25 GMT
miRagen Therapeutics Initiates First Clinical Trial for Anti-Fibrosis Product ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Diagnostic Laboratories

Shares Out. (M)

0.74

Shares Float (M)

0.48

% Held by Insiders

% Held by Institutions

Shares Short (K)

22

Shares Short Prior Month (K)

78

Stock Financials

EPS

-14.100

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

6.510

PEG Ratio

Profit Margin

Operating Margin

-308.40

Return on Assets (ttm)

-55.9

Return on Equity (ttm)

-116.4

Qtrly Rev. Growth

77.4

Gross Profit (p.s.)

Sales Per Share

4.369

EBITDA (p.s.)

-13.215

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.65

Levered Free Cash Flow (M)

-2.88

FoxReading.com

Valuation

P/E

-0.87

P/E Growth Ratio

-0.15

P/BV

1.89

P/S

2.82

P/CF

-1.37

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.